Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer
Year: 2008
Type: article
Source: European Journal of Cancer
Institutions: European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer, Vall d'Hebron Hospital Universitari, Sir Charles Gairdner Hospital, Centre Hospitalier Universitaire de Rouen, Kantonsspital St. Gallen, VA Connecticut Healthcare System, Charles University, Fakultní nemocnice Bulovka, National Cancer Institute
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2127143471
